<DOC>
	<DOCNO>NCT02939495</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Dapoxetine/Sildenafil 30/50 mg film-coated tablet treatment men premature ejaculation erectile dysfunction .</brief_summary>
	<brief_title>The Efficacy Safety Dapoxetine/Sildenafil Combination Therapy</brief_title>
	<detailed_description>During 4-weeks treatment period , patient take one Dapoxetine/Sildenafil 30/50 mg film coat tablet 1-3 hour sexual intercourse . Study drug use 1 tablet every 24 hour treatment .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1864 year old men , Participants must heterosexual male stable monogamous sexual relationship female partner least 6 month continue throughout study , Clinical diagnosis erectile dysfunction , IIEF score ≤21 , Premature Ejaculation Diagnostic Tool ( PEDT ) score must ≥11 Patients lifelong PE acquire PE accord description International Society Sexual Medicine ( ISSM ) , The patient partner must sexual intercourse twice week duration study , Commitment comply study protocol , Patients sign inform consent form ( ICF ) . History medical event surgical intervention neurologic condition ( e.g. , multiple sclerosis ) , trauma , infection associate development symptom premature ejaculation ( PE ) consider potential cause PE , Having genital abnormality , except penile curvature unless prevent sexual intercourse , Developed ED PE due drug use quit take drug , Any condition prevent sexual intercourse partner History epilepsy , Severe renal insufficiency , Liver disease , History last 6 month stroke , myocard infarction , cardiac insufficiency ( New York Cardiovascular Associates ( NYCA ) phase IIIV ) , AV block message disorder sick sinus syndrome , severe ischemic cardiac disease , syncope , unstable angına , lifethreatening arrhythmia hypotension , NonArteritic Anterior ischemic optic neuropathy , Patients eligible sexual intercourse due exist health problem , Autonomic neuropathy , retinitis pigmentosa , blood disease , active peptic ulcer , abnormality ECG , severe systemic disease control , Systolic/Diastolic blood pressure rest &lt; 90/50mmHg 170/100mmHg &lt; History allergy Selective Serotonine Reuptake Inhibitor ( SSRI ) phosphodiesterase inhibitor drug , Continuing use quit last 3 month Monoamine oxidase inhibitor ( MAOI ) , Thioridazine , Serotonine Reuptake Inhibitor ( SSRI ) , SelectiveNorepinephrin Reuptake Inhibitor ( SNRI ) , Serotonergic drug/herbal product , tricyclic antidepressant atypical antipsychotic drug , Use nitrate , alfa blocker , vasodilator , ketoconazole , itraconazole , ritonavir , saquinavir , telithromycin , nefazodone , nelfinavir , atazanavir , cimetidine , erithromicin , clarithromycin , fluconazole , amprenavir , fosamprenavir , aprepitant , verapamil , diltiazem , kind vasodilator , antiplatelet , anticoagulant , dapoxetine , PDE5 inhibitor , alcohol stimulant drug , Patients different therapy ( behavioral therapy drug apply locally ) PE treatment During study , possibility take medication may affect study drug 's pharmacokinetic/pharmacodynamic property Patients define symptom prostatitis clinically Thyroid hormone disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Premature Ejaculation</keyword>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>DAP-SPEED</keyword>
	<keyword>Dapoxetine</keyword>
	<keyword>Sildenafil</keyword>
</DOC>